1607 Capital Partners’s BlackRock Health Sciences Trust BME Stock Holding History

1607 Capital Partners’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.98M	Buy	233,260 +4,000	+2%	+$165K	0.65%	35
2025 Q4	$9.43M	Buy	229,260 +75,958	+50%	+$3M	0.64%	37
2025 Q3	$5.71M	Sell	153,302 -200	-0.1%	-$7.27K	0.43%	55
2025 Q2	$5.6M	Buy	153,502 +12,393	+9%	+$449K	0.45%	56
2025 Q1	$5.45M	Sell	141,109 -34,903	-20%	-$1.38M	0.44%	55
2024 Q4	$6.68M	Sell	176,012 -89,302	-34%	-$3.57M	0.54%	51
2024 Q3	$11.1M	Buy	265,314 +37,520	+16%	+$1.56M	1.02%	33
2024 Q2	$9.31M	Buy	227,794 +104,317	+84%	+$4.15M	0.83%	39
2024 Q1	$5.12M	Sell	123,477 -48,265	-28%	-$2.02M	0.42%	65
2023 Q4	$6.95M	Buy	171,742 +83,650	+95%	+$3.19M	0.49%	59
2023 Q3	$3.45M	Buy	+88,092	New	+$3.51M	0.26%	88
2018 Q2	–	Sell	-13,405	Closed	-$469K	–	107
2018 Q1	$469K	Buy	+13,405	New	+$477K	0.03%	109

Other funds holding BME

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

1607 Capital Partners's BME Position: Q1 2026 in Review

1607 Capital Partners increased its BlackRock Health Sciences Trust (BME) stake by 1.7% in Q1 2026, buying an estimated $165K and bringing the position to 233,260 shares worth $8.98M. The position accounts for 0.65% of the portfolio, ranked #35.

1607 Capital Partners first reported a position in BME in Q1 2018 and has held it in 12 quarters since. The position peaked at $11.1M in Q3 2024. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

1607 Capital Partners held 233,260 shares of BlackRock Health Sciences Trust worth $8.98M as of Q1 2026.
1607 Capital Partners bought 4,000 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $165K.
BlackRock Health Sciences Trust made up 0.65% of 1607 Capital Partners's portfolio in Q1 2026, its #35 holding.
1607 Capital Partners first reported a position in BlackRock Health Sciences Trust in Q1 2018 and has held it in 12 quarters since.
1607 Capital Partners's BlackRock Health Sciences Trust position peaked at $11.1M in Q3 2024.
76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on 1607 Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.